Rein Therapeutics Inc.

Rein Therapeutics Inc.verified

RNTX

Price:

$1.39

Market Cap:

$36.54M

Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. The company was founded by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky on August 6, 2001 and is headquartered in Austin, TX.

Industry

Medical - Pharmaceuticals

IPO Date

2017-06-29

Stock Exchange

NASDAQ

Ticker

RNTX

The Enterprise Value as of December 2025 (TTM) for Rein Therapeutics Inc. (RNTX) is 32.49M

According to Rein Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 32.49M. This represents a change of 280.34% compared to the average of 8.54M of the last 4 quarters.

Rein Therapeutics Inc. (RNTX) Historical Enterprise Value (quarterly & annually)

How has RNTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Rein Therapeutics Inc. over the last ten years is -5028435.94. The current 32.49M Enterprise Value has changed -64710.83% with respect to the historical average. Over the past ten years (40 quarters), RNTX's Enterprise Value was at its highest in in the June 2025 quarter at 28.14M. The Enterprise Value was at its lowest in in the June 2024 quarter at -21874788.68.

Quarterly (TTM)
Annual

Average

-5028435.94

Median

-5222188.66

Minimum

-20715000.00

Maximum

30.29M

Rein Therapeutics Inc. (RNTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Rein Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 449.76%

Maximum Annual Enterprise Value = 30.29M

Minimum Annual Increase = -10957.56%

Minimum Annual Enterprise Value = -20715000.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024-12823742.60-25.68%
2023-17255252.24234.96%
2022-5151377.3250.25%
2021-3428587.20-111.32%
202030.29M-10957.56%
2019-279000.00-94.73%
2018-5293000.00-55.38%
2017-11863000.00-42.73%
2016-20715000.00449.76%

Rein Therapeutics Inc. (RNTX) Average Enterprise Value

How has RNTX Enterprise Value performed in the past?

The current Enterprise Value of Rein Therapeutics Inc. (RNTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-11743457.39

5-year avg

-1673271.87

10-year avg

-5028435.94

Rein Therapeutics Inc. (RNTX) Enterprise Value vs. Peers

How is RNTX’s Enterprise Value compared to its peers?

Rein Therapeutics Inc.’s Enterprise Value is less than Inotiv, Inc. (417.47M), greater than HeartBeam, Inc. (22.89M), greater than 111, Inc. (-3531321.52), greater than Tempest Therapeutics, Inc. (9.57M), less than BioAtla, Inc. (47.72M), greater than Kezar Life Sciences, Inc. (20.85M), less than Celularity Inc. (112.66M), greater than Actinium Pharmaceuticals, Inc. (-7013958.00), less than Mersana Therapeutics, Inc. (83.22M), less than Quantum BioPharma Ltd. (38.94M),

CompanyEnterprise ValueMarket cap
417.47M$30.19M
22.89M$24.75M
-3531321.52$32.68M
9.57M$15.19M
47.72M$49.86M
20.85M$45.77M
112.66M$47.46M
-7013958.00$45.23M
83.22M$137.32M
38.94M$38.17M

Build a custom stock screener for Rein Therapeutics Inc. (RNTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rein Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rein Therapeutics Inc. (RNTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rein Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Rein Therapeutics Inc.'s Enterprise Value?

What is the highest Enterprise Value for Rein Therapeutics Inc. (RNTX)?

What is the 3-year average Enterprise Value for Rein Therapeutics Inc. (RNTX)?

What is the 5-year average Enterprise Value for Rein Therapeutics Inc. (RNTX)?

How does the current Enterprise Value for Rein Therapeutics Inc. (RNTX) compare to its historical average?